Letters in Drug Design & Discovery

G. Perry
University of Texas
San Antonio, TX
USA
Email: lddd@benthamscience.org

Back

CETP Inhibitory Activity of Chlorobenzyl Benzamides: QPLD Docking, Pharmacophore Mapping, and Synthesis

(E-pub Abstract Ahead of Print)

Author(s): Reema Abu Khalaf, Hamada Abd El-Aziz, Dima Sabbah, Ghadeer Albadawi, Ghassan Abu Sheikha.

Abstract:

Elevated levels of serum LDL and total cholesterol are considered important risk factors for the development of atherosclerosis. Cholesteryl ester transfer protein inhibition raises HDL levels and reduces atherosclerotic lesions. Consequently, there is a great interest in developing new CETP inhibitors. Herein, synthesis of four chlorobenzyl benzamides 8a-d that aim at CETP inhibition was performed. Benzamide 8a showed the best CETP inhibitory activity with an IC50 of 1.6 µM. In vitro biological data shows that the presence of p-trifluoromethoxy group enhances CETP inhibitory activity more than m-trifluoromethyl groups. QPLD docking shows that the verified compounds accommodate the binding cleft of CETP and are enclosed by hydrophobic lining. The scaffold of 8a-d matches the pharmacophoric points of CETP inhibitors; particularly hydrophobic and aromatic functionalities. Future structural modification is needed to improve CETP inhibitory activity and to enhance understanding of the structure-activity relationship.

Keywords: Atherosclerosis, CETP inhibitors, Chlorobenzyl benzamides, Docking, QPLD, Pharmacophore mapping.

Rights & PermissionsPrintExport

Article Details

VOLUME: 14
Year: 2017
(E-pub Abstract Ahead of Print)
DOI: 10.2174/1570180814666170412122304
Price: $95